Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded a site-wide funding/status notice and the page revision tag v3.4.1, and removed the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check9 days agoChange DetectedThe page now shows a glossary toggle and new metadata lines (Last Update Submitted that Met QC Criteria; Revision: v3.4.0; No FEAR Act Data). The older QC criterion line and the previous No FEAR Act data wording were removed or changed.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedPage revision label updated from v3.3.3 to v3.3.4; no changes to study content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe study locations section now shows a separate 'Locations' heading with 'Ontario' listed, replacing the previous 'Ontario Locations' label. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision note updated from v3.2.0 to v3.3.2; no study data or content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedRemoved the government funding/operating-status notice, including statements about potential delays due to funding and links to operating status resources. The page no longer displays this general status information.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.